Second Sight eyes $10M funding round | Wall Street Beat

Thu, 07/25/2013 - 11:39am
Mass Device

Second Sight Medical registers for a $10 million funding round to back its Argus II 'bionic eye' retinal implant.

Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market.

The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina.

The Sylmar, Calif.-based medical device company won pre-market approval from the FDA for the Argus II in February.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.